Dr. Edward Harper

In Japan We Treat Both Sides Of MS. America Only Treats One.

I treated MS in Japan for 18 years. When I moved to America, I couldn't believe what doctors here were telling their patients. I've been a neurologist for 20 years. The first 18, I practiced in Osaka. I moved to the United States two years ago when my husband's company transferred him to Boston. I joined a neurology practice here. Good practice. Good doctors. And in my first three months, I saw something that kept me up at night. Women in their 40s, 50s, and 60s coming in with stable MRIs and bodies that were quietly falling apart. Walking slower every year. Exhausted by early afternoon. Losing words mid-sentence. A hand on the wall in every hallway. Every one of them said the same thing. "My doctor says my scans are stable." Stable. In Japan, we don't watch a patient get worse every year under stable scans and call it success. We address both sides of the disease, the attacks and the repair. Because by the time someone's walking has slowed for five straight years despite perfect scans, something has already failed, structurally, systemically, and adding another prescription for the fatigue to a nervous system that is running on stripped nerves won't rebuild a coating that came off years ago and never grew back. It only manages what's already damaged. Here's what your doctor probably hasn't told you about what MS progression actually is. A stable MRI is not a picture of whether or not your nerves are healing properly. It's a picture of no new attacks. Every old attack left patches of nerve exposed. Signals crossing those patches move slower and use far more energy than they should. So you feel exhausted, your thinking slows down, and your walking gets harder, even though the attacks stopped years ago. The infusion suppresses the immune attack, and it does that well. But stopping new attacks is the only thing it was designed to do. It was never meant to repair the damage the old attacks left behind. The symptom prescriptions help you get through the day. Modafinil for the fatigue. Baclofen for the stiffness. They cover the symptom for a few hours. The exposed nerve underneath stays exactly as it was. The advice is all worth doing. Exercise, rest, sleep, diet. But it works around the damage. It doesn't give your nerves anything to rebuild the coating with. The infusion controls the attacks. The prescriptions cover the symptoms. The advice works around the damage. Nothing repairs it. Published research has documented for years that progression without new lesions, what neurologists now call PIRA, progression independent of relapse activity, is driven by the old damage, not by new attacks. Patients decline for years with perfectly stable scans. Not laziness. Not aging. Not "just MS being MS." A two-sided disease treated as a one-sided problem. Your medication isn't the problem. The protocol treating stability as the finish line is. I want to be honest about the infusions. Because most of my Boston patients are on one, and some have been for a decade. The infusion suppresses the immune attack. It's the correct treatment for the attack side, and it should get credit. The relapses stop. The new lesions stop. What the infusion can't do is rebuild stripped coating AND supply the material AND deliver it inside the nerve cell. It closes the road to new damage. It does nothing about the damage already done. Fifteen years of MS can mean a dozen attacks before treatment ever started, each one stripping coating that was never rebuilt. None of that shows up on a report that only counts new lesions. You cannot out-suppress damage that size for long. The treatment holds. The scans stay clean. The function slides. Because the damage was never repaired. Suppressing attacks over old damage is like patching the roof of a house the storm already flooded. Nothing new gets in. Nothing inside gets fixed. I've seen it in patient after patient here. Treatment working perfectly on paper. No relapses in six years. And the 25-foot walk still creeping up. Seven seconds becomes eight. Eight becomes nine and a half. They start needing to lie down by 3pm. They start stopping mid-sentence because they cannot remember ordinary words. Because nothing had rebuilt the coating AND supplied the materials AND delivered them inside the nerve cell. This is what nobody tells you about where the unrepaired damage leads. It doesn't stay at just the ‘fatigue’. An exposed nerve is not stable. Without its coating, the nerve fiber itself starts to break down. Signals that used to arrive slowly stop arriving at all. Walking fails next, because the nerves that control the legs are the longest in the body and cross the most damaged patches. Then balance. Then memory. Then bladder control. One symptom at year two becomes three by year five. Five by year ten. By year twelve you're on a stack of prescriptions that barely hold the line. I've had the conversation that follows more times than I should have. With women who did everything their doctor told them. Who never missed an infusion appointment. Who did the physical therapy, took the vitamin D, paced themselves exactly as instructed. Who still, year over year, watched their walking slow and their thinking follow. The infusion addressed the attacks. The unrepaired damage kept getting worse. Silently, steadily, until the decline wasn't dismissible as aging anymore and the only options offered were mobility aids or living with it. When I arrived in the US, I assumed the research simply hadn't made it here yet. In Japan, we treat MS as a two-sided disease. Stopping the attacks is one side. Rebuilding the nerve coating is the other. The repair side emerged from Japanese neurology research in the early 1980s, neurologists studying why some patients kept declining after their attacks stopped and others didn't, despite identical scans and identical medications. What they found was that the difference was never attack control. The steady decliners had the same clean scans. What they did not have was repair. The old damage stayed exposed year after year, and their bodies never rebuilt it. It wasn't treatment failure. It was repair failure.* That research led to trials on whether rebuilding the coating with the active form of B12, methylcobalamin, combined with repair energy from B1, clean signal support from B6, and delivery inside the nerve cell from liposomes, could restart the repair without another prescription. In cases where the unrepaired damage was the primary issue, not new attacks. Nerve research calls the three of them the neurotropic vitamins. Published neurology research documented direct nerve support with the neurotropic vitamins at clinical dosages. Documented remyelination from methylcobalamin, prescribed for nerve damage in Japan since the early 1980s, with nerves regenerating at about one millimeter per day.* Documented improvement in fatigue from high-dose B1 in people with MS, within days.* Documented clean signal support from B6 in its active form. Documented the liposome, a microscopic sphere made of the same material as your own cell membranes, carrying compounds through the gut intact and releasing them inside the cell, where the repair actually happens. Combined, the three-vitamin liposomal protocol supplies the material AND the energy AND the clean signaling, delivered inside the nerve cell, reaching the side of the disease the infusion was never designed to touch. No prescription needed. No additional appointments. Continuous supply until the repair has what it needs. I want to tell you about one patient. Because her results are what I see when people finally address the right side. She was 56. Diagnosed at 44. Her scans had been stable for six years, and her 25-foot walk had not come in under nine seconds in any of them. Her previous neurologist had told her to prepare for a cane. She came to me for a second opinion. Her compliance was perfect. The decline was real. The unrepaired side was the problem. In Japan, before we ever accept decline as the baseline, we ask one question: has the repair been supplied? The infusion addresses the attack side. It does not supply material, energy, or delivery, and it does not touch the damage already there. I recommended 90 days of supplying the repair before making any decisions about a cane. She was skeptical. Six years of perfect compliance hadn't bought back a single half second. She didn't believe drops could change what six years of perfect treatment hadn't. I explained it simply. The infusion puts out the fire. That's what it does. It does not rebuild what already burned. Your walking isn't slowing because the medication is weak. It's slowing because fifteen years of damage has never been rebuilt, and nothing you've been given was ever designed to rebuild it. You can stop every new attack perfectly. If the old damage is still exposed, nothing improves. She agreed to try. Stedman. The three neurotropic vitamins in their active forms. Methylcobalamin at 5,000 micrograms. B1. B6 as P-5-P. All of it sealed in liposomes. One drop with breakfast. Week 1: Nothing dramatic. The 3pm crash still came. But she was back on her feet by four instead of done for the night. Week 2: First real energy at 5pm. She climbed her own staircase without stopping on the landing and without pulling herself up on the rail. Week 4: The words she needed came on the first try, without the pause her family had learned to wait through. She read in the evening again and could still follow the page at nine o'clock. Week 8: 25-foot walk, 8.1 seconds. From 9.6. The first real improvement in six years. A full week without lying down in the afternoon. Her legs still got heavy at the end of a long day. But heavy like tired legs, not heavy like legs that refuse to move. She cried. Week 12: Her previous neurologist, the one who told her to prepare for a cane, pulled up her chart. Then pulled it up again. "Walk time 7.7. Steady gait. No cane necessary at this time." She didn't need the cane. She didn't need to spend the next decade shrinking her life around the decline. In Japan, this is where we start. Not with monitoring. With the repair. I share this because I spent two years quietly frustrated by what I see here. Women who came to me after years of being told their scans looked great, while the unrepaired damage got worse every year, until they were lying down every afternoon, stopping mid-sentence to find ordinary words, and planning errands around how far their legs could carry them. Women who felt like they were failing. Like their bodies were betraying them despite doing everything right. They weren't failing. The protocol was failing them. American neurology training focuses on attack suppression and symptom management. Repair-side protocols, giving the nerves what they need to rebuild the coating, aren't part of standard training. Most American doctors graduated before this research was emphasized. They practice what they were taught. That's not a criticism. It's just where the knowledge gap sits. But the research exists. And you don't have to wait for your doctor to find it. If your scans have been stable for years while you keep getting slower, if you're sleeping more than ever and still running out of energy by mid afternoon, if you've been told it's aging or deconditioning but you know your body, The answer isn't to monitor more closely. It's to supply the repair your treatment was never designed to do. I'll leave a link below to the product I recommend to my own patients. I have no financial relationship with this company. I recommend it because the mechanism is sound, the research supports it, and I've seen it work. You've spent years doing what you were told. It's time to address what you were never told. 90-day money-back guarantee. One drop with breakfast. Your body isn't failing you. The protocol treating stability as success is what's failing you. Two sides. One formula. Supply the side no one else does. https://trystedman.com